Response.
Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (BAMHG, MJH); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR).
B A M
BA
Heemskerk-Gerritsen
Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (BAMHG, MJH); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR).
M J
MJ
Hooning
Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands (BAMHG, MJH); Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (MAR).
M A
MA
Rookus
D019313:BRCA1 Protein / Q000235:genetics*; D024682:BRCA2 Protein / Q000235:genetics*; D001943:Breast Neoplasms / Q000453:epidemiology* / Q000517:prevention & control*; D005260:Female; D006579:Heterozygote; D006801:Humans; D010052:Ovariectomy; D040242:Risk Reduction Behavior; D058994:Salpingectomy
D019313:BRCA1 Protein; D024682:BRCA2 Protein